6Kirn D,Martuza RJ,Zwjebel J,Replication selective virotherapy for cancer:biological principles,risk management and future directions[J].Nat Med,2001,7 (7);781-787.
7Stojdl DF,Lichty B,Knowles S,et al.Exploiting tumorspecific defects in the interferon pathway with a previously unknownoncolytic virus[J].Nat Med,2000,6 (7);821-825.
8NemunaitisJ,KhuriF,Ganly I,etal.Phase Ⅱ trialof intratumoral administration of ONYX-015,a replication selective adenovirus,in patients with refractory head and neck cancer[J].J Clin Oncol,2001,19 (2); 289-298.
9Ries S,Korn WM.ONYX-015:mechanisms of action and clinical potential of a replication selective adenovirus[J].Br J Cancer,2002,86 (1);5-11.
10Harris JR,The evolution of placental[J].mammals.FEBS Lett,1991,295:3-4.
